TBX-1400

N/A

Report date: 2024/11/08 20:00:30

Base Information

Drug NameTBX-1400
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionImmunostimulantsStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsSevere Combined Immunodeficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaiga Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiga Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsSevere Combined Immunodeficiency

Other Information

ATC CodeN/A
Related LinksN/A